Detailed answers about KOSAVALI GROUP MEDICAL PRODUCT LTD, including incorporation, status, business activity, and accounts information.
When was KOSAVALI GROUP MEDICAL PRODUCT LTD founded?
KOSAVALI GROUP MEDICAL PRODUCT LTD was officially incorporated on 1 May 2025 and is registered under company number 16424929. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is KOSAVALI GROUP MEDICAL PRODUCT LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of KOSAVALI GROUP MEDICAL PRODUCT LTD?
KOSAVALI GROUP MEDICAL PRODUCT LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does KOSAVALI GROUP MEDICAL PRODUCT LTD do?
KOSAVALI GROUP MEDICAL PRODUCT LTD operates in the following sectors: 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 47910 - Retail sale via mail order houses or via Internet, 86210 - General medical practice activities. These SIC codes provide insight into the company's business activities and industry focus.
What is KOSAVALI GROUP MEDICAL PRODUCT LTD's registered address?
The registered office address of KOSAVALI GROUP MEDICAL PRODUCT LTD is 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is KOSAVALI GROUP MEDICAL PRODUCT LTD financially stable?
Financial accounts for KOSAVALI GROUP MEDICAL PRODUCT LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.